RenBio Announces New Awards to Support Continued Development of Its Novel, DNA-Based MYO Technology™ Platform for Antiviral Applications

Posted on by

$2.9 Million Received From Wellcome for DNA-Based Delivery of Antiviral Antibodies for Zika and Influenza Prevention, Focusing on Preclinical Development of a Potent Anti-Zika Antibody and Optimizing Antibody Cocktail Delivery $749,000 Contract from the BARDA Flexible and Strategic…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.